Japan · Delayed Price · Currency is JPY Genetec Statistics
Total Valuation
Genetec has a market cap or net worth of JPY 4.43 billion. The enterprise value is 4.66 billion.
| Market Cap | 4.43B |
| Enterprise Value | 4.66B |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Sep 29, 2026 |
Share Statistics
Genetec has 11.57 million shares outstanding. The number of shares has increased by 0.27% in one year.
| Current Share Class | 11.57M |
| Shares Outstanding | 11.57M |
| Shares Change (YoY) | +0.27% |
| Shares Change (QoQ) | -2.26% |
| Owned by Insiders (%) | 69.61% |
| Owned by Institutions (%) | 5.32% |
| Float | 2.75M |
Valuation Ratios
The trailing PE ratio is 8.99.
| PE Ratio | 8.99 |
| Forward PE | n/a |
| PS Ratio | 0.40 |
| PB Ratio | 1.72 |
| P/TBV Ratio | 3.11 |
| P/FCF Ratio | 96.34 |
| P/OCF Ratio | 39.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.30, with an EV/FCF ratio of 101.28.
| EV / Earnings | 9.37 |
| EV / Sales | 0.42 |
| EV / EBITDA | 4.30 |
| EV / EBIT | 5.70 |
| EV / FCF | 101.28 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.42 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 1.68 |
| Debt / FCF | 39.50 |
| Interest Coverage | 27.27 |
Financial Efficiency
Return on equity (ROE) is 20.39% and return on invested capital (ROIC) is 16.90%.
| Return on Equity (ROE) | 20.39% |
| Return on Assets (ROA) | 7.83% |
| Return on Invested Capital (ROIC) | 16.90% |
| Return on Capital Employed (ROCE) | 23.19% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | 17.02M |
| Profits Per Employee | 766,975 |
| Employee Count | 648 |
| Asset Turnover | 1.69 |
| Inventory Turnover | 24.27 |
Taxes
In the past 12 months, Genetec has paid 305.00 million in taxes.
| Income Tax | 305.00M |
| Effective Tax Rate | 38.03% |
Stock Price Statistics
The stock price has decreased by -21.74% in the last 52 weeks. The beta is 0.66, so Genetec's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -21.74% |
| 50-Day Moving Average | 399.18 |
| 200-Day Moving Average | 442.80 |
| Relative Strength Index (RSI) | 37.95 |
| Average Volume (20 Days) | 14,555 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genetec had revenue of JPY 11.03 billion and earned 497.00 million in profits. Earnings per share was 42.60.
| Revenue | 11.03B |
| Gross Profit | 4.18B |
| Operating Income | 818.00M |
| Pretax Income | 802.00M |
| Net Income | 497.00M |
| EBITDA | 1.08B |
| EBIT | 818.00M |
| Earnings Per Share (EPS) | 42.60 |
Balance Sheet
The company has 1.59 billion in cash and 1.82 billion in debt, with a net cash position of -227.00 million or -19.62 per share.
| Cash & Cash Equivalents | 1.59B |
| Total Debt | 1.82B |
| Net Cash | -227.00M |
| Net Cash Per Share | -19.62 |
| Equity (Book Value) | 2.57B |
| Book Value Per Share | 222.14 |
| Working Capital | 1.14B |
Cash Flow
In the last 12 months, operating cash flow was 112.00 million and capital expenditures -66.00 million, giving a free cash flow of 46.00 million.
| Operating Cash Flow | 112.00M |
| Capital Expenditures | -66.00M |
| Depreciation & Amortization | 266.25M |
| Net Borrowing | -190.00M |
| Free Cash Flow | 46.00M |
| FCF Per Share | 3.98 |
Margins
Gross margin is 37.86%, with operating and profit margins of 7.41% and 4.51%.
| Gross Margin | 37.86% |
| Operating Margin | 7.41% |
| Pretax Margin | 7.27% |
| Profit Margin | 4.51% |
| EBITDA Margin | 9.83% |
| EBIT Margin | 7.41% |
| FCF Margin | 0.42% |
Dividends & Yields
This stock pays an annual dividend of 12.50, which amounts to a dividend yield of 3.26%.
| Dividend Per Share | 12.50 |
| Dividend Yield | 3.26% |
| Dividend Growth (YoY) | 5.56% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.27% |
| Shareholder Yield | 2.98% |
| Earnings Yield | 11.21% |
| FCF Yield | 1.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2023. It was a forward split with a ratio of 3.
| Last Split Date | Dec 28, 2023 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
Genetec has an Altman Z-Score of 3.64 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.64 |
| Piotroski F-Score | 6 |